Cargando…
Case Report: Identification of a Novel GNAS Mutation and 1p/22q Co-Deletion in a Patient With Multiple Recurrent Meningiomas Sensitive to Sunitinib
BACKGROUND: Although surgical resection can cure the majority of meningiomas, there are still approximately 20% of patients suffering from an aggressive course with recurrence or progression. In this study, we reported a novel GNAS mutation and 1p/22q co-deletion responding to sunitinib in a patient...
Autores principales: | Hong, Weiping, Shan, Changguo, Ye, Minting, Yang, Yanying, Wang, Hui, Du, Furong, Zhang, Xing, Song, Chao, Cai, Linbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554081/ https://www.ncbi.nlm.nih.gov/pubmed/34722286 http://dx.doi.org/10.3389/fonc.2021.737523 |
Ejemplares similares
-
Deletions in the 17q chromosomal region and their influence on the clonal cytogenetic evolution of recurrent meningiomas
por: Hemmer, Sina, et al.
Publicado: (2019) -
EGFR amplification is a putative resistance mechanism for NSCLC–LM patients with TKI therapy and is associated with poor outcome
por: Yang, Hainan, et al.
Publicado: (2022) -
Efficacy and safety of combined immunotherapy and stereotactic radiosurgery in NSCLCBM patients and a novel prognostic nomogram: A real-world study
por: Bashir, Shoaib, et al.
Publicado: (2023) -
Case Report: Recurrent meningioma with multiple metastases
por: Zhou, Juyue, et al.
Publicado: (2023) -
LMD-06. A NSCLC patient with leptomeningeal metastasis harboring rare EGFR mutations G719S and L861Q benefited from doubling dosage of osimertinib: a case report
por: Wang, Hui, et al.
Publicado: (2021)